Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 07.03. - 11:00 Uhr
CannaPharmaRx to Hold Investor Conference Call
CALGARY, AB / ACCESSWIRE / March 7, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Tuesday, March19, 2024 at 2PM Eastern time to give an update on the year to date progress of CannaPharmaRx Inc. Chief Executive Officer Dean Medwid will be presenting with the topics being discussed will include: Review of 2023 Operational Activities Licensing Update Product Update Supply Partner(s) Update Forecasted Revenues Interested parties can join the conference call by dialing in as directed below. North American Toll Free: 1-530-881-1212 Passcode: 1674609 PIN: 615253385# Passcode: 1674609 An archived replay of the webcast will be available at: https://investors.trulieve.com/events Please visit www.cannapharmarx.com for additional information about our company and products About CannapharmaRx, Inc. CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. » Mehr auf accesswire.com
- 13.07. - 12:00 Uhr
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
CALGARY, AB / ACCESSWIRE / July 13, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the sale of its Hanover, Ontario facility for $2,000,000 CAD. The Hanover facility includes ten acres of land and 48,800 square feet of growing space. » Mehr auf accesswire.com
- 24.06. - 12:30 Uhr
CannaPharmaRx Comments on Stock Promotion Flag
CALGARY, AB / ACCESSWIRE / June 24, 2021 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced that it has been brought to its attention that a Third Party has issued a Press Release. Management believes this update is from an unaffiliated third party posting information about the company. » Mehr auf accesswire.com
Unternehmenszahlen
(EUR) | Sep. 2023 | |
---|---|---|
Umsatz | 0,00 | - |
Bruttoeinkommen | 11,34 | - |
Nettoeinkommen | 533,10k | - |
EBITDA | 430,29k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 3,17 Mio € |
Anzahl Aktien | 337,96 Mio |
52 Wochen-Hoch/Tief | 0,0262 € - 0,000656 € |
Dividenden | Nein |
Beta | -1.190,54 |
KGV (PE Ratio) | 0,39 |
KGWV (PEG Ratio) | 0,01 |
KBV (PB Ratio) | 0,14 |
KUV (PS Ratio) | 135,43 |
Unternehmensprofil
CannaPharmaRX, Inc. ist in der Cannabisbranche in Kanada tätig. Das Unternehmen verhandelt, erwirbt und entwickelt verschiedene Cannabisanbauprojekte. Das Unternehmen wurde 1998 gegründet und hat seinen Sitz in Calgary, Kanada.
Name | CANNAPHARMARX A DL-,0001 |
CEO | Dean P. Medwid |
Sitz | Calgary,
ab USA |
Website | |
Industrie | Chemikalien |
Börsengang | 16.04.2015 |
Mitarbeiter | 6 |
Ticker Symbole
Börse | Symbol |
---|---|
Otc | CPMD |
Pnk | CPMD |
Assets entdecken
Shareholder von CANNAPHARMARX A DL-,0001 investieren auch in folgende Assets
-
-
-
-
-
-
-
-
-
-